Published on: 24 January 2020 Roche provides an update on Phase III study of Tecentriq in people with muscle-invasive urothelial cancer more
Published on: 23 January 2020 Roche’s Risdiplam meets primary endpoint in pivotal FIREFISH trial in infants with type 1 spinal muscular atrophy more
